Literature DB >> 23306903

Cardiac MRI detected septal and lateral myocardial infarction by alcohol septal ablation through the intermediate artery.

Mike Saji1, Itaru Takamisawa, Nobuo Iguchi, Morimasa Takayama.   

Abstract

A 65-year-old woman with hypertrophic obstructive cardiomyopathy presented with dyspnea. Transthoracic echocardiography showed severe mitral regurgitation (MR) due to systolic anterior motion and a peak gradient of 102 mmHg across the LV outflow. Cardiac magnetic resonance imaging (CMR) showed patchy late gadolinium enhancement in the hypertrophied septum. Because of non-responsiveness to medical treatment, percutaneous alcohol septal ablation (ASA) was conducted. The septal perforator that supplied the hypertrophic myocardium originated from the intermediate artery. A 2.0-mm over-the-wire balloon was used to occlude the intermediate artery and 1.1 ml of ethanol was injected slowly into the target septal perforator branch. The gradient decreased markedly to 5 mmHg immediately after ASA, and electrocardiogram showed right bundle branch block. Echocardiographic findings at 1 week were satisfactory. However, CMR showed delayed enhancement in both the hypertrophic basal septum and the lateral wall. The clinical course was uneventful, and she has maintained NHYA functional class 1 so far. In this case, proximal migration of the balloon or an undersized occluding balloon may have caused lateral infarction through leakage of ethanol into another branch. CMR is a useful modality to verify whether the ASA procedure has induced the appropriate controlled infarction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23306903     DOI: 10.1007/s00380-012-0317-7

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  16 in total

1.  The risk of alcohol leakage into the left anterior descending coronary artery during non-surgical myocardial reduction in patients with obstructive hypertrophic cardiomyopathy.

Authors:  P P Dimitrow; D Dudek; J S Dubeil
Journal:  Eur Heart J       Date:  2001-03       Impact factor: 29.983

2.  Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients.

Authors:  C Knight; A S Kurbaan; H Seggewiss; M Henein; M Gunning; D Harrington; D Fassbender; U Gleichmann; U Sigwart
Journal:  Circulation       Date:  1997-04-15       Impact factor: 29.690

3.  Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: the perfect septal branch may originate from an atypical location.

Authors:  Stéphane Noble; Caroline Frangos; Philippe L L'allier
Journal:  Can J Cardiol       Date:  2012-01-25       Impact factor: 5.223

Review 4.  Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.

Authors:  Mahboob Alam; Hisham Dokainish; Nasser Lakkis
Journal:  J Interv Cardiol       Date:  2006-08       Impact factor: 2.279

5.  Regional left ventricular contractile dynamics in hypertrophic cardiomyopathy evaluated by magnetic resonance imaging.

Authors:  T Sato; H Yamanari; T Ohe; T Yoshinouchi
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

6.  Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.

Authors:  H Seggewiss; U Gleichmann; L Faber; D Fassbender; H K Schmidt; S Strick
Journal:  J Am Coll Cardiol       Date:  1998-02       Impact factor: 24.094

7.  Septal myomectomy and mitral valve replacement for idiopathic hypertrophic subaortic stenosis: short- and long-term follow-up.

Authors:  S Fighali; Z Krajcer; R D Leachman
Journal:  J Am Coll Cardiol       Date:  1984-05       Impact factor: 24.094

8.  Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.

Authors:  J Kazmierczak; Z Kornacewicz-Jach; M Kisly; R Gil; A Wojtarowicz
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

9.  Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry.

Authors:  H Kuhn; H Seggewiss; F H Gietzen; P Boekstegers; L Neuhaus; L Seipel
Journal:  Z Kardiol       Date:  2004-01

10.  Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alcohol (1 ml) is still effective.

Authors:  Josef Veselka; David Zemánek; Pavol Tomasov; Radka Duchonová; Katerina Linhartová
Journal:  Heart Vessels       Date:  2009-01-23       Impact factor: 2.037

View more
  3 in total

1.  Effects of alcohol septal ablation on left ventricular diastolic filling patterns in obstructive hypertrophic cardiomyopathy.

Authors:  You-Zhou Chen; Fu-Jian Duan; Jian-Song Yuan; Feng-Huan Hu; Jin-Gang Cui; Wei-Xian Yang; Yan Zhang; Hao Wang; Shu-Bin Qiao
Journal:  Heart Vessels       Date:  2015-03-05       Impact factor: 2.037

2.  Significant reduction of left atrial volume concomitant with clinical improvement after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy, and its precise detection with multidetector CT.

Authors:  Yuichiro Maekawa; Keitaro Akita; Hikaru Tsuruta; Yoshitake Yamada; Kentaro Hayashida; Shinsuke Yuasa; Mitsushige Murata; Masahiro Jinzaki; Keiichi Fukuda
Journal:  Open Heart       Date:  2016-06-03

3.  Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis.

Authors:  Makoto Sano; Hiroshi Satoh; Kenichiro Suwa; Mamoru Nobuhara; Takeji Saitoh; Masao Saotome; Tsuyoshi Urushida; Hideki Katoh; Kumiko Shimoyama; Daisuke Suzuki; Noriyoshi Ogawa; Yasuo Takehara; Harumi Sakahara; Hideharu Hayashi
Journal:  Heart Vessels       Date:  2014-07-05       Impact factor: 2.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.